Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Aclarion (ACON) Research & Development (2021 - 2026)

Aclarion filings provide 5 years of Research & Development readings, the most recent being $263130.0 for Q4 2025.

  • On a quarterly basis, Research & Development rose 4.49% to $263130.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $1.0 million, a 16.32% increase, with the full-year FY2025 number at $1.0 million, up 16.32% from a year prior.
  • Research & Development hit $263130.0 in Q4 2025 for Aclarion, down from $302037.0 in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $353226.0 in Q2 2022 to a low of $162714.0 in Q2 2021.
  • Median Research & Development over the past 5 years was $219838.0 (2022), compared with a mean of $232586.8.
  • Biggest five-year swings in Research & Development: skyrocketed 117.08% in 2022 and later tumbled 31.86% in 2023.
  • Aclarion's Research & Development stood at $182101.0 in 2021, then rose by 20.26% to $218997.0 in 2022, then grew by 0.77% to $220679.0 in 2023, then grew by 14.11% to $251826.0 in 2024, then rose by 4.49% to $263130.0 in 2025.
  • The last three reported values for Research & Development were $263130.0 (Q4 2025), $302037.0 (Q3 2025), and $270434.0 (Q2 2025) per Business Quant data.